Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Boston Medical Group vs Noom Med

Boston Medical Group
Graded #279

Lower grade

vs+6.600000000000001
Noom Med
Graded #146

Higher grade

The verdict

Noom Med takes it — 68.5/100 to 61.9/100.

Noom Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Noom Med integrates GLP-1 medication access with Noom's proven cognitive behavioral therapy curriculum, 1-on-1 dietitian coaching, and dedicated care team — the most comprehensive psychology-plus-medication…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNoom Med +36
54
90
Dose & formulationBoston Medical Group +12
52
40
Clinical oversightBoston Medical Group +12
89
77
Labs & monitoringNoom Med +10
53
63
FulfillmentNoom Med +8
65
73
Contract termsEven
55
55
Boston Medical Group · left barNoom Med · right bar

The numbers

MetricBoston Medical GroupNoom Med
WeighScore61.9/10068.5/100
GradeCC
Scorecard rank#279#146
Semaglutide$199/mo (starting strength, rising with dose, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
Coverage7 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Boston Medical Group

Graded #279 · C

Strengths

  • An established medical group with a defined 12-week programme rather than an open-ended subscription
  • The price range and the 12-week total are both published, once you reach the costs page
  • Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight

Where it loses points

  • The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
  • The 12-week programme totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
  • The weight-loss landing page carries no price at all; the numbers are two pages deeper, in the FAQ and the costs page
  • Semaglutide and tirzepatide are not priced separately — one range covers the whole programme
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Noom Med

Graded #146 · C

Strengths

  • Combines GLP-1 medication with CBT behavior change
  • Dedicated dietitian included in every plan
  • Highest support score in fitness app category
  • Integrated care team for medication and coaching
  • Noom's proven behavioral curriculum

Where it loses points

  • Available in only 40 states — excludes AK, HI, ID, MT, NM, SD, VT, WV, WY, ND
  • More expensive than app-only alternatives
  • Requires commitment to both medication and coaching program

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard